Toby H. Richardson
Chief Executive Officer at Denovium, Inc.
Profile
Toby H.
Richardson is the founder of Denovium, Inc. He currently holds the position of Director at CRISPRQC, Inc. and Vice President-Bioinformatics at Viridos, Inc. He formerly worked as a Principal at Diversa Corp.
Dr. Richardson received his undergraduate and doctorate degrees from the University of Surrey.
Toby H. Richardson active positions
| Companies | Position | Start |
|---|---|---|
Viridos, Inc.
 Viridos, Inc. Miscellaneous Commercial ServicesCommercial Services Viridos, Inc. develops and commercializes genomic-driven solutions and products. The firm's offerings are designed for application in solutions such as human health, food, water production, and environment. The company was founded by J. Craig Venter, Hamilton O. Smith, David C. Kiernan and Juan Enriquez-Cabot in February 2005 and is headquartered in La Jolla, CA. | Corporate Officer/Principal | 2009-07-29 |
Denovium, Inc.
 Denovium, Inc. Packaged SoftwareTechnology Services Part of Absci Corp., Denovium, Inc. is an American artificial intelligence company that pioneers novel AI methods to accelerate innovation in biology. Denovium is building an artificial intelligence engine (Denovium EngineTM) capable of interpreting disparate biological data types to answer biology's toughest questions. The company partners with leading biotech and pharma companies in specific areas of focus, including gene discovery, protein engineering, and genomic medicine. The company was founded by Toby H. Richardson, Ariel Schwartz, Imad Ajjawi, and Gregory Hannum, with Toby H. Richardson serving as the CEO since incorporation. Denovium was acquired by Absci Corp. on January 12, 2021 for $4 million. | Chief Executive Officer | - |
CRISPRQC, Inc.
 CRISPRQC, Inc. BiotechnologyHealth Technology CRISPRQC, Inc. provides a comprehensive crispr analytics platform that enables scientists and researchers to optimize gene editing outcomes and ensure the highest levels of quality control. The company is based in San Diego, CA. The platform is built on the company's proprietary crispr-chip technology, which allows for direct, real-time measurement of crispr activity. The company strives to empower its customers with the insights needed to push forward the life-saving cures and sustainable agricultural advances fueled by crispr editing. CRISPRQC was founded by Ross Bundy and Kiana Aran, with Ross Bundy serving as the CEO since incorporation. | Director/Board Member | - |
Former positions of Toby H. Richardson
| Companies | Position | End |
|---|---|---|
Diversa Corp.
 Diversa Corp. Miscellaneous Commercial ServicesCommercial Services Diversa searches high and low for DNA. In its quest to develop new enzymes and other active biological compounds, the biotechnology company collects and catalogs the DNA of organisms in diverse environments (from manure piles to tropical islands). A variety of manufacturers license these compounds from the firm to develop or improve their products, which include detergents, oils, animal feeds, and pharmaceuticals. Diversa's products include enzymes for the oil and gas industry | Corporate Officer/Principal | - |
Training of Toby H. Richardson
| University of Surrey | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Diversa Corp.
Diversa Corp. Miscellaneous Commercial ServicesCommercial Services Diversa searches high and low for DNA. In its quest to develop new enzymes and other active biological compounds, the biotechnology company collects and catalogs the DNA of organisms in diverse environments (from manure piles to tropical islands). A variety of manufacturers license these compounds from the firm to develop or improve their products, which include detergents, oils, animal feeds, and pharmaceuticals. Diversa's products include enzymes for the oil and gas industry | Commercial Services |
Viridos, Inc.
Viridos, Inc. Miscellaneous Commercial ServicesCommercial Services Viridos, Inc. develops and commercializes genomic-driven solutions and products. The firm's offerings are designed for application in solutions such as human health, food, water production, and environment. The company was founded by J. Craig Venter, Hamilton O. Smith, David C. Kiernan and Juan Enriquez-Cabot in February 2005 and is headquartered in La Jolla, CA. | Commercial Services |
Denovium, Inc.
Denovium, Inc. Packaged SoftwareTechnology Services Part of Absci Corp., Denovium, Inc. is an American artificial intelligence company that pioneers novel AI methods to accelerate innovation in biology. Denovium is building an artificial intelligence engine (Denovium EngineTM) capable of interpreting disparate biological data types to answer biology's toughest questions. The company partners with leading biotech and pharma companies in specific areas of focus, including gene discovery, protein engineering, and genomic medicine. The company was founded by Toby H. Richardson, Ariel Schwartz, Imad Ajjawi, and Gregory Hannum, with Toby H. Richardson serving as the CEO since incorporation. Denovium was acquired by Absci Corp. on January 12, 2021 for $4 million. | Technology Services |
CRISPRQC, Inc.
CRISPRQC, Inc. BiotechnologyHealth Technology CRISPRQC, Inc. provides a comprehensive crispr analytics platform that enables scientists and researchers to optimize gene editing outcomes and ensure the highest levels of quality control. The company is based in San Diego, CA. The platform is built on the company's proprietary crispr-chip technology, which allows for direct, real-time measurement of crispr activity. The company strives to empower its customers with the insights needed to push forward the life-saving cures and sustainable agricultural advances fueled by crispr editing. CRISPRQC was founded by Ross Bundy and Kiana Aran, with Ross Bundy serving as the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Toby H. Richardson